Clinical Trials Browser

Terminated × Hematologic Neoplasms × encorafenib × Clear all

NCT01981187 2021-03-26

SIGNATURE

Phase 2 Terminated

12 enrolled 13 charts

Other hematologic neoplasm

Hematologic Neoplasms